SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QGLY - Funny Name Great Product. -- Ignore unavailable to you. Want to Upgrade?


To: Ironyman who wrote (8665)12/10/1998 6:15:00 AM
From: drakes353  Respond to of 8960
 
That was a good call on ABTX,,,

Thanks but I'm looking for ABTX to drop down to $8 or lower. So my "call" has not yet been validated.

However QGLY doesn't have any debt problems to deal with and is rolling into their largest sales period.

Every short ain't exactly like every other one. This is a declining sales and earnings story. ABTX is a silly expectations story.

There is very little down side

There is downside to $5 and below, IMHO.

and large upside potential.

No without increases in sales and earnings. Dave would have you believe those increases will be coming next year. But he's been saying prosperity was 'round the next bend for months now.

The published number of shorts decreased as of November,,,,Yet you appear to be hanging on even with Koffmans and Morgans buying shares.

Why ?


I'll hang around until the goes below $5 or sales and earnings start to rise. This continues to play out like CNXS quote.yahoo.com

drakes353